A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1
Open Access
- 1 August 1997
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (35) , 22330-22339
- https://doi.org/10.1074/jbc.272.35.22330
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Insulin-induced egr-1 and c-fos Expression in 32D Cells Requires Insulin Receptor, Shc, and Mitogen-activated Protein Kinase, but Not Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase ActivationJournal of Biological Chemistry, 1996
- Cannabinoid receptor stimulation of guanosine-5′-O-(3-[35S]thio)triphosphate binding in rat brain membranesLife Sciences, 1996
- Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brainLife Sciences, 1996
- The Cubic Ternary Complex Receptor–Occupancy Model II. Understanding Apparent AffinityJournal of Theoretical Biology, 1996
- The Cubic Ternary Complex Receptor–Occupancy Model I. Model DescriptionJournal of Theoretical Biology, 1996
- GTP‐binding protein‐activator sequences in the insulin receptorFEBS Letters, 1993
- The MAP kinase cascade is essential for diverse signal transduction pathwaysTrends in Biochemical Sciences, 1993
- Mastoparan, a novel mitogen for Swiss 3T3 cells, stimulates pertussis toxin-sensitive arachidonic acid release without inositol phosphate accumulation.The Journal of cell biology, 1991
- Insulin affects the ability of Gi to be ADP-ribosylated but does not elicit its phosphorylation in intact hepatocytesBiochemical and Biophysical Research Communications, 1989